[go: up one dir, main page]

GB202303232D0 - New medical uses - Google Patents

New medical uses

Info

Publication number
GB202303232D0
GB202303232D0 GBGB2303232.9A GB202303232A GB202303232D0 GB 202303232 D0 GB202303232 D0 GB 202303232D0 GB 202303232 A GB202303232 A GB 202303232A GB 202303232 D0 GB202303232 D0 GB 202303232D0
Authority
GB
United Kingdom
Prior art keywords
new medical
medical uses
new
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2303232.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atrogi AB
Original Assignee
Atrogi AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrogi AB filed Critical Atrogi AB
Priority to GBGB2303232.9A priority Critical patent/GB202303232D0/en
Publication of GB202303232D0 publication Critical patent/GB202303232D0/en
Priority to PCT/EP2024/051316 priority patent/WO2024153813A1/en
Priority to EP24701833.6A priority patent/EP4651867A1/en
Priority to CN202480008369.9A priority patent/CN120583945A/en
Ceased legal-status Critical Current

Links

GBGB2303232.9A 2023-01-20 2023-03-06 New medical uses Ceased GB202303232D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2303232.9A GB202303232D0 (en) 2023-03-06 2023-03-06 New medical uses
PCT/EP2024/051316 WO2024153813A1 (en) 2023-01-20 2024-01-19 Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
EP24701833.6A EP4651867A1 (en) 2023-01-20 2024-01-19 Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
CN202480008369.9A CN120583945A (en) 2023-01-20 2024-01-19 Beta2-adrenergic receptor agonists for the treatment or prevention of muscle wasting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2303232.9A GB202303232D0 (en) 2023-03-06 2023-03-06 New medical uses

Publications (1)

Publication Number Publication Date
GB202303232D0 true GB202303232D0 (en) 2023-04-19

Family

ID=85980107

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2303232.9A Ceased GB202303232D0 (en) 2023-01-20 2023-03-06 New medical uses

Country Status (1)

Country Link
GB (1) GB202303232D0 (en)

Similar Documents

Publication Publication Date Title
GB2638927B (en) Patient interface
GB202007929D0 (en) New medical uses
GB202302225D0 (en) New medical uses
GB202205895D0 (en) New medical uses
ZAA202201461S (en) Medical devices
GB202312653D0 (en) New medical uses
GB202306258D0 (en) New medical uses
GB202303232D0 (en) New medical uses
GB202303229D0 (en) New medical uses
GB202302194D0 (en) New medical uses
GB202300857D0 (en) New medical uses
GB202212071D0 (en) New medical uses
GB202205900D0 (en) New medical uses
GB202111911D0 (en) New medical uses
GB202314100D0 (en) New medical use
GB202302278D0 (en) New medical use
GB202013014D0 (en) New medical uses
GB202219368D0 (en) New medical use
GB202217810D0 (en) Medical use
GB202216910D0 (en) Medical use
GB202509980D0 (en) New medical uses
CA225227S (en) Patient interface
GB202501574D0 (en) New medical uses
GB202410820D0 (en) New medical uses
GB202407432D0 (en) New medical uses

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)